Summary
The pharmacokinetics of fluocortolone and its effect on the circadian rhythm of plasma cortisol and ACTH have been studied during different schedules of oral administration. Groups of 6 healthy male adults were given a single daily dose of fluocortolone 5, 10 and 20 mg, and another group received 20 mg every second day. Administration to all groups was continued for 8 days.
Pharmacokinetic parameters of fluocortolone (half lives of absorption- t1/2a and elimination t1/2e, volume of distribution V and oral clearance (CL/f) were independent of the duration of treatment and dose. Areas under the plasma level curves, AUC and Cmax values increased in proportion to the dose, indicating dose linearity of fluocortolone pharmacokinetics.
A normal morning cortisol peak occurred during all treatment schedules, which indicates that circadian cortisol secretion was not seriously affected by the glucocorticoid treatment. On the other hand, when the level of circulating fluocortolone was high the 12.00 a.m. and 4.00 p.m. cortisol levels were diminished compared to the pre and posttreatment values. There was no definite correlation between the ACTH and cortisol levels, either on treatment or on control days. ACTH levels were suppressed by daily treatment with the 20 mg dose.
Thus, even during administration of a high dose of a glucocorticoid, the circadian secretion of cortisol can be preserved if the treatment is adjusted according to the half-life of the drug.
Similar content being viewed by others
References
Krieger D (1979) Rhythm in CRF, ACTH and corticosteroids. In: Krieger DT (ed) Endocrine rhythms. Raven Press, New York, pp 123–142
Täuber U, Haack D, Nieuweboer B, Kloss G, Vecsei P, Wendt H (1984) The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. Int J Clin Pharmacol Ther Tox 22: 48–55
Täuber U, Richter K, Matthes H (1986) Fluocortolone: Pharmacokinetics and effect on plasma cortisol level. Eur J Clin Pharmacol 30: 433–438
Lopatta F, Vecsei P, Täuber U, Haack D (19869) Pharmakokinetik von Fluocortolon in der Langzeittherapie von Patienten mit rheumatischen und hämatologischen Erkrankungen. Arzneimittelforsch Drug Res 36: 1268–1271
Fehm HL, Holl R, Klein E, Voigt KH (1983) The meal-related peak in plasma cortisol is not mediated by radioimmunoassayable ACTH. Clin Physiol Biochem 1: 329–333
Fehm HL, Klein E, Holl R, Voigt KH (1984) Evidence for extrapituitary mechanisms mediating the “morning peak” of plasma cortisol in man. J Clin Endocrinol Metab 58: 410–414
Voigt KH, Bossert S, Bretschneider St, Rockstroh B, Fehm HL (1983) Disturbance of cortisol secretion in depressive patients: Lack of correlations with plasma ACTH. In: Endröczi E (ed) Neuropeptides and psychosomatic processes. Académiai Kiadno, Budapest, p 593
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Täuber, U., Posern, U., Bickel, U. et al. Fluocortolone: Pharmacokinetics and effect on ACTH and cortisol secretion during daily and alternate-day administration. Eur J Clin Pharmacol 35, 177–181 (1988). https://doi.org/10.1007/BF00609249
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609249